FTI Consulting, Inc. FCN
Composite 48/100; the shares have moved about 31% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 26/100 — a moderate mark against it.
Valuation ranks 62/100 — a slight point in its favour. Balance-sheet strength ranks 55/100 — a slight point in its favour. Quality ranks 51/100 — a slight point in its favour.
Momentum ranks 26/100 — a moderate mark against it. Growth ranks 38/100 — a moderate mark against it.
What the company does FTI Consulting provides business advisory services across Corporate Finance, Forensic and Litigation Consulting, Economic Consulting, Technology, and Strategic Communications. It serves sectors like aerospace, healthcare, and financial services, focusing on change management, risk mitigation, and dispute resolution.
Key financials FTI shows solid profitability with ROE 14%, ROA 7.2%, and net margins of 6.9%. Revenue and EPS growth are both 9%+, while gross margins stand at 31.9%. Debt/Equity is 0.61 with interest coverage of 14.73 and a current ratio of 2.30.
Stock health Momentum is weak: -8.52% over 3m, -8.47% over 6m, and -4.10% over 12m. The stock is 13.34% below its 52-week high, with RSI(14) at 56.30. The SidraVest score ranks Valuation at 65.1 but Momentum at just 30.8.
Price vs fair value The stock trades at a PREMIUM of 40.90% versus our fair-value estimate of 97.03 and a discount of 4.85% to the analyst 12-month target of 172.00. - Q2 2026 sales met estimates, with in-line guidance (StockStory, 2026-07-30) - Simply Wall St. flags potential 6% undervaluation (2026-07-31) - Multiple earnings call summaries highlight steady performance (Motley Fool, MarketBeat, Moby, 2026-07-31/30)
Looking forward Forward P/E is 18.90 with EV/EBITDA at 12.35, suggesting moderate valuation relative to growth. Analysts see limited upside to current levels, while fundamental metrics support steady cash generation and profitability.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.